Predictive cytokines of omalizumab in the treatment of chronic spontaneous urticaria
CSU patients with high levels of IL-2, IL-13, IL-31, and IL-33 may potentially benefit from omalizumab treatment.
Authors
- Rongfei Zhu (ORCID: https://orcid.org/0000-0003-2103-3381)
- Lin Yang (ORCID: https://orcid.org/0000-0001-8746-9255)
- Yin Wang (ORCID: https://orcid.org/0000-0002-9030-2568)
- Hao Chen (ORCID: https://orcid.org/0009-0001-6480-7976)
- Ping Ting Ji (ORCID: https://orcid.org/0000-0002-2608-1035)
- Guanghui Liu (ORCID: https://orcid.org/0009-0007-8991-0551)
- Yaqi Yang (ORCID: https://orcid.org/0000-0002-5604-5190)
Institutions
- Wuhan University (CN)
- Zhongnan Hospital of Wuhan University (CN)
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Cytokine
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1016/j.cyto.2024.156814
- Citations
- 3
- Primary Topic
- Urticaria and Related Conditions
- Type
- article
- Field-Weighted Citation Impact
- 1.41